Allen Capital Group’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.61M Buy
50,190
+10,087
+25% +$950K 0.29% 73
2026
Q1
$4.74M Buy
40,103
+1,926
+5% +$238K 0.42% 55
2025
Q4
$4.8M Buy
38,177
+9,904
+35% +$1.29M 0.44% 56
2025
Q3
$4.14M Buy
28,273
+2,458
+10% +$372K 0.39% 62
2025
Q2
$4.03M Buy
25,815
+22,886
+781% +$3.63M 0.41% 59
2025
Q1
$482K Buy
2,929
+505
+21% +$84K 0.05% 167
2024
Q4
$395K Sell
2,424
-42
-2% -$7.51K 0.05% 174
2024
Q3
$482K Buy
2,466
+467
+23% +$86K 0.06% 147
2024
Q2
$347K Buy
1,999
+435
+28% +$72.4K 0.05% 160
2024
Q1
$265K Buy
+1,564
New +$293K 0.04% 178

Other funds holding ZTS

Allen Capital Group's ZTS Position: Q2 2026 in Review

Allen Capital Group increased its Zoetis (ZTS) stake by 25% in Q2 2026, buying an estimated $950K and bringing the position to 50,190 shares worth $3.61M. The position accounts for 0.29% of the portfolio, ranked #73.

Allen Capital Group first reported a position in ZTS in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.8M in Q4 2025. 1,430 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Allen Capital Group held 50,190 shares of Zoetis worth $3.61M as of Q2 2026.
  • Allen Capital Group bought 10,087 Zoetis shares in Q2 2026, an estimated $950K.
  • Zoetis made up 0.29% of Allen Capital Group's portfolio in Q2 2026, its #73 holding.
  • Allen Capital Group first reported a position in Zoetis in Q1 2024 and has held it in 10 quarters since.
  • Allen Capital Group's Zoetis position peaked at $4.8M in Q4 2025.
  • 1,430 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Allen Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.